SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001609351-17-000069
Filing Date
2017-07-07
Accepted
2017-07-07 16:40:19
Documents
1
Period of Report
2017-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_149946000555109.html 4  
1 FORM 4 wf-form4_149946000555109.xml 4 6936
  Complete submission text file 0001609351-17-000069.txt   8349
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Issuer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address
Marrazzo Jeffrey D (Reporting) CIK: 0001631262 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36819 | Film No.: 17955588